P-glycoprotein: one mechanism, many tasks and the consequences for pharmacotherapy of cancers

A Seelig - Frontiers in oncology, 2020 - frontiersin.org
P-glycoprotein or multidrug resistance protein (MDR1) is an adenosine triphosphate (ATP)
binding cassette transporter (ABCB1) intensely investigated because it is an obstacle to …

Multidrug resistance in cancer: role of ATP–dependent transporters

MM Gottesman, T Fojo, SE Bates - Nature reviews cancer, 2002 - nature.com
Chemotherapeutics are the most effective treatment for metastatic tumours. However, the
ability of cancer cells to become simultaneously resistant to different drugs—a trait known as …

Targeting multidrug resistance in cancer

G Szakács, JK Paterson, JA Ludwig… - Nature reviews Drug …, 2006 - nature.com
Effective treatment of metastatic cancers usually requires the use of toxic chemotherapy. In
most cases, multiple drugs are used, as resistance to single agents occurs almost …

Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy

R Silva, V Vilas-Boas, H Carmo… - Pharmacology & …, 2015 - Elsevier
Abstract P-glycoprotein (P-gp) is an ATP-dependent efflux pump encoded by the MDR1
gene in humans, known to mediate multidrug resistance of neoplastic cells to cancer …

Clinical perspective of FDA approved drugs with P-glycoprotein inhibition activities for potential cancer therapeutics

JI Lai, YJ Tseng, MH Chen, CYF Huang… - Frontiers in …, 2020 - frontiersin.org
P-glycoprotein (also known as multidrug resistance protein 1 (MDR1) or ATP-binding
cassette sub-family B member 1 (ABCB1) plays a crucial role in determining response …

A "Silent" Polymorphism in the MDR1 Gene Changes Substrate Specificity

C Kimchi-Sarfaty, JM Oh, IW Kim, ZE Sauna… - Science, 2007 - science.org
Synonymous single-nucleotide polymorphisms (SNPs) do not produce altered coding
sequences, and therefore they are not expected to change the function of the protein in …

Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and …

S Hoffmeyer, O Burk, O Von Richter… - Proceedings of the …, 2000 - National Acad Sciences
To evaluate whether alterations in the multidrug-resistance (MDR)-1 gene correlate with
intestinal MDR-1 expression and uptake of orally administered P-glycoprotein (PGP) …

Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment

RJ Dinis-Oliveira, JA Duarte… - Critical reviews in …, 2008 - Taylor & Francis
Paraquat dichloride (methyl viologen; PQ) is an effective and widely used herbicide that has
a proven safety record when appropriately applied to eliminate weeds. However, over the …

Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease

JJM Smit, AH Schinkel, RPJO Elferink, AK Groen… - Cell, 1993 - cell.com
Two types of P-glycoprotein have been found in mammals: the drug-transporting P-
glycoproteins and a second type, unable to transport hydrophobic anticancer drugs. The …

Role of P-glycoprotein in pharmacokinetics: clinical implications

JH Lin, M Yamazaki - Clinical pharmacokinetics, 2003 - Springer
P-glycoprotein, the most extensively studied ATP-binding cassette (ABC) transporter,
functions as a biological barrier by extruding toxins and xenobiotics out of cells. In vitro and …